07.24.25 -- Essential Steps For A Successful Analytical Tech Transfer

Explore the common pitfalls encountered in CGT CDMO collaborations, including communication breakdowns, differing regulatory interpretations, and program prioritization challenges.

Learn how a platform streamlines LVV titer measurement, offering a faster and more efficient alternative to traditional methods and addressing key process development challenges.

Boost rAAV yields and quality while reducing costs with our proprietary HEK293 cell line and scalable, optimized manufacturing platform for gene therapy.

Consider how Buoyancy Activated Cell Sorting (BACS) can streamline T cell isolation, reduce costs, and enhance CAR T and TCR cell therapy manufacturing — access the full study to learn more.

Discover how 3PBIOVIAN’s advanced plasmid manufacturing and AAVion® platform can drive your AAV program forward by reducing production costs while maximizing efficiency.

With real-world examples and a vision that challenges the prevailing norms of biotech commercialization, this conversation offers a powerful look at what it takes to reshape the future of healthcare.

Explore a high-strength synthetic gene promoter that boosts titers while preserving product quality and expression stability for more efficient biomanufacturing.

Scaling up viral vector production can be challenging, and ensuring consistent titers and activity requires careful optimization and technical expertise.

Learn how delivering a comprehensive CMC package under a single manufacturer can help to minimize the logistical complexity of multiple vendors that leads to major risks for RNA program success.